Skip to content

Melanoma/Skin Cancer Health Center

New Test Helps Unmask Melanoma

Font Size
A
A
A
By
WebMD Health News

March 9, 2000 (Atlanta) -- A new test to help identify melanoma -- the deadliest and most common form of skin cancer -- will someday be available to labs across the country, according to a presentation at the annual meeting of the International Society of Dermatopathology. The test detects abnormalities that researchers at the University of California, San Francisco (UCSF), have linked with melanoma.

Melanoma is so deadly because it has the ability to spread to other parts of the body. In the U.S. in 1999, over 7,000 people died from the disease, making it the ninth most common cancer. It can be cured if it is diagnosed and treated early, before spreading.

Melanomas usually arise from moles. These moles have suddenly or gradually become larger or irregular, or have changed color or shape. Despite these changes, it is sometimes difficult for physicians to differentiate a benign, or harmless, mole from a dangerous one. This delays accurate diagnosis and treatment.

At the meeting, Philip LeBoit, MD, a professor of pathology at UCSF, presented summaries of two papers. The papers discuss a new technique that may one day help pathologists -- doctors who work in labs diagnosing diseases -- more accurately diagnose melanoma.

"This [new diagnostic technique] is how melanoma diagnosis will be made in the 21st century," LeBoit tells WebMD. Called comparative genomic hybridization (CGH), the test was developed by co-author Dan Pinkel, PhD, a professor at UCSF's Comprehensive Cancer Center. "When we began applying it, we found pretty clear-cut results," says LeBoit. "It will be especially useful in the hardest-to-diagnose cases -- those 5% of melanoma cases that even top pathologists can't distinguish from non-cancerous under the microscope."

In their study, researchers analyzed 100 samples of diagnosed melanoma cases. Using CGH, they found that all but one had detectable abnormalities. Most tumors had two, three, or four of the abnormalities, says LeBoit. CGH works by using fluorescent dyes to identify changes in cancer cell chromosomes. Chromosomes are parts of genes, the "building blocks" of the body.

In another study using CGH, researchers did not find these same abnormalities in benign moles. They conclude that pathologists can use these abnormalities as markers for melanoma.

Today on WebMD

Malignant melanoma
About 40-50 percent of those who live to be 65 may get it. Here’s how to spot early.
Woman checking out tan lines
There’s a dark side to that strive for beauty. See them here.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
 
12 Ways to Protect Your Skin from Melanoma
ARTICLE
precancerous lesions slideshow
SLIDESHOW
 
Do You Know Your Melanoma ABCs
VIDEO
15 Cancer Symptoms Men Ignore
ARTICLE
 
screening tests for men
SLIDESHOW
Vitamin D
SLIDESHOW
 
Is That Mole Skin Cancer
VIDEO
Brilliant sun rays
Quiz
 

WebMD Special Sections